David Remillard

1.6k total citations
11 papers, 797 citations indexed

About

David Remillard is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, David Remillard has authored 11 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Hematology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in David Remillard's work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (6 papers) and Multiple Myeloma Research and Treatments (6 papers). David Remillard is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (6 papers) and Multiple Myeloma Research and Treatments (6 papers). David Remillard collaborates with scholars based in United States, Germany and Netherlands. David Remillard's co-authors include James E. Bradner, Scott A. Armstrong, Gerard L. Brien, Sirano Dhe‐Paganon, Hyuk‐Soo Seo, Dennis L. Buckley, Nathanael S. Gray, Joshiawa Paulk, Matthew Sonnett and Martin Wühr and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Cell Biology.

In The Last Decade

David Remillard

11 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Remillard United States 10 725 184 153 147 68 11 797
Steven DellaRocca United States 7 515 0.7× 177 1.0× 53 0.3× 39 0.3× 55 0.8× 12 629
Ying-Wei Lin United States 9 340 0.5× 202 1.1× 236 1.5× 93 0.6× 21 0.3× 9 557
Ernest Medina United States 6 444 0.6× 160 0.9× 45 0.3× 89 0.6× 46 0.7× 9 607
P. Buhl-Jensen United Kingdom 10 467 0.6× 202 1.1× 56 0.4× 59 0.4× 32 0.5× 13 564
Ugo Consoli United States 10 271 0.4× 199 1.1× 64 0.4× 132 0.9× 21 0.3× 15 550
K. Martin Kortuem United States 10 667 0.9× 276 1.5× 53 0.3× 557 3.8× 19 0.3× 20 853
Sho Kubota Japan 16 369 0.5× 122 0.7× 30 0.2× 97 0.7× 30 0.4× 46 552
Victoria Grandage United Kingdom 9 492 0.7× 177 1.0× 58 0.4× 472 3.2× 21 0.3× 16 926
Shane W. O’Brien United States 12 401 0.6× 188 1.0× 44 0.3× 59 0.4× 34 0.5× 14 602
Ju In Eom South Korea 8 362 0.5× 121 0.7× 32 0.2× 118 0.8× 23 0.3× 10 475

Countries citing papers authored by David Remillard

Since Specialization
Citations

This map shows the geographic impact of David Remillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Remillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Remillard more than expected).

Fields of papers citing papers by David Remillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Remillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Remillard. The network helps show where David Remillard may publish in the future.

Co-authorship network of co-authors of David Remillard

This figure shows the co-authorship network connecting the top 25 collaborators of David Remillard. A scholar is included among the top collaborators of David Remillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Remillard. David Remillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tao, Yongfeng, Zhongyu Zou, Evert Njomen, et al.. (2023). Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2. Angewandte Chemie International Edition. 62(51). e202311924–e202311924. 40 indexed citations
2.
Zhang, Yuxiang, David Remillard, Joshua N. Asiaban, et al.. (2023). Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. Nature Structural & Molecular Biology. 30(8). 1160–1171. 15 indexed citations
3.
Sewastianik, Tomasz, Hyuk‐Soo Seo, David Remillard, et al.. (2022). A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science Advances. 8(17). eabm3108–eabm3108. 26 indexed citations
4.
Tao, Yongfeng, David Remillard, Ekaterina V. Vinogradova, et al.. (2022). Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1. Journal of the American Chemical Society. 144(40). 18688–18699. 72 indexed citations
5.
Remillard, David, Nikolas A. Savage, Alexia T. Kedves, et al.. (2021). Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8. ACS Chemical Biology. 16(11). 2185–2192. 5 indexed citations
6.
Remillard, David, Dennis L. Buckley, Hyuk‐Soo Seo, et al.. (2019). Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold. ACS Medicinal Chemistry Letters. 10(10). 1443–1449. 12 indexed citations
7.
Michel, Brittany C., Seth H. Cassel, Nazar Mashtalir, et al.. (2018). A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nature Cell Biology. 20(12). 1410–1420. 248 indexed citations
8.
Brien, Gerard L., David Remillard, Junwei Shi, et al.. (2018). Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma. eLife. 7. 148 indexed citations
9.
Remillard, David, Dennis L. Buckley, Joshiawa Paulk, et al.. (2017). Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. Angewandte Chemie. 129(21). 5832–5837. 15 indexed citations
10.
Remillard, David, Dennis L. Buckley, Joshiawa Paulk, et al.. (2017). Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. Angewandte Chemie International Edition. 56(21). 5738–5743. 204 indexed citations
11.
Koblan, Luke W., Dennis L. Buckley, Christopher J. Ott, et al.. (2016). Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET‐BRET. ChemMedChem. 11(23). 2575–2581. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven DellaRocca Breakdown of academic impact, for papers by Ying-Wei Lin Breakdown of academic impact, for papers by Ernest Medina Breakdown of academic impact, for papers by P. Buhl-Jensen Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by K. Martin Kortuem Breakdown of academic impact, for papers by Sho Kubota Breakdown of academic impact, for papers by Victoria Grandage Breakdown of academic impact, for papers by Shane W. O’Brien Breakdown of academic impact, for papers by Ju In Eom
Rankless by CCL
2026